Danaher Corp. (DHR) Tops Q2 EPS by 2c; Guides Q3 Below Views
Tweet
Share
E-mailGet Alerts DHR Hot Sheet
Price: $203.89 -0.92%
Financial Fact:
Research and development expenses: -241.1M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Research and development expenses: -241.1M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Danaher Corp. (NYSE: DHR) reported Q2 EPS of $0.87, $0.02 better than the analyst estimate of $0.85. Revenue for the quarter came in at $4.7 billion versus the consensus estimate of $4.72 billion.
Sees Q3 2013 EPS of $0.78-$0.83, versus the consensus of $0.84.
Sees FY2013 EPS of $3.37-$3.42, versus prior guidance of $3.32-$3.47 and the consensus of $3.41.
For earnings history and earnings-related data on Danaher Corp. (DHR) click here.
Sees Q3 2013 EPS of $0.78-$0.83, versus the consensus of $0.84.
Sees FY2013 EPS of $3.37-$3.42, versus prior guidance of $3.32-$3.47 and the consensus of $3.41.
For earnings history and earnings-related data on Danaher Corp. (DHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
- KULR Technology Group (KULR) Misses Q2 EPS by 39c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
